Heidi Ko/LinkedIn
May 24, 2025, 07:06
Heidi Ko Will Present a Poster on Immune Expression Profiles of Pancreatic Adenocarcinoma at ASCO 2025
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:
“Happy Friday!
Can’t believe ASCO25 is only a week away! The energy is building as we gear up for one of the most important events in oncology.
I’m presenting a poster on immune expression profiles of pancreatic adenocarcinoma in the track:
Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary
Saturday May 31st from 9:00 am to 12:00 CDT.I’m looking forward to an incredible lineup of pivotal trials, especially in breast cancer, that are going to be practice-changing and reconnecting with colleagues and friends across the field.
If you’ll be at ASCO25, let’s connect! Stop by our Labcorp booth 30119 or click the link below to schedule a meeting!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023